论文部分内容阅读
目的与方法 :本院自 1989年 6月～ 1997年 12月间对晚期肺癌病人行手术治疗共 155例。结果 :全胸术后1、3、5年的生存率分别为 70 3%、2 4 5%、7 1% ,中位生存率为 2 1个月。结论 :①晚期肺癌的某些转移或侵犯的症状及体征并不是手术的绝对禁忌症。②术中应注意观察SAO2 及CO2 浓度等重要指标的改变 ,术中即使出现R( +)现象 ,手术仍具临床价值。术中配合多种现今先进的手术方式 ,能达到理想的治疗效果。③术后应严密监测及积极处理并发症。④病理分期是影响 5年生存率的主要因素。⑤开展晚期肺癌的外科治疗 ,是对肺癌进行综合治疗的一个重要手段。
Objectives and Methods: A total of 155 cases of advanced lung cancer patients were treated surgically between June 1989 and December 1997 in this hospital. Results: The survival rates of 1, 3, and 5 years after total thoracic surgery were 70 3%, 24%, and 71%, respectively. The median survival rate was 21 months. Conclusion :1 The symptoms and signs of certain metastasis or invasion of advanced lung cancer are not absolute contraindications to surgery. 2 During operation, attention should be paid to the changes of important indexes such as SAO2 and CO2 concentration. Even if R(+) phenomenon occurs during surgery, the operation still has clinical value. Intraoperative cooperation with a variety of advanced surgical methods can achieve the desired therapeutic effect. 3 should be closely monitored and actively deal with complications after surgery. 4 pathological stage is the main factor affecting the 5-year survival rate. 5 Surgical treatment for advanced lung cancer is an important means for comprehensive treatment of lung cancer.